Wang Aihua, Yu Sangjie, Yao Kaihu, Zhang Wenshuang, Yuan Lin, Wang Yonghong, Wei Jinghai, Shen Xuzhuang, Yang Yonghong
Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
Pediatr Pulmonol. 2008 May;43(5):457-62. doi: 10.1002/ppul.20789.
To investigate the nasopharyngeal carriage and antimicrobial susceptibility of H. influenzae among children younger than 5 years old and to assess antibiotics usage patterns in the outpatient department of Beijing Children's Hospital from 2000 to 2004.
From 2000 to 2004, At least 100 strains of H. influenzae were isolated from the pediatric patients who were younger than 5 years and who presented with symptoms of acute upper respiratory tract infections during February to May in each of the study years. Antimicrobial susceptibilities were determined; and antibiotics usage was expressed as defined daily dose (DDD)/100 patient days.
The overall nasopharyngeal carriage rate of H. influenzae is 26.3% (562/2,137) in children younger than 5 years old with acute upper respiratory tract infection. The percentage of ampicillin-resistant isolates ranges from 4.0% (4/100) to 14.3% (17/119) from 2000 to 2004. All the ampicillin-resistant isolates are beta-lactamase producers. More than 80% of the isolates are susceptible to amoxicillin, cefaclor, and chloramphenicol; whereas, almost all (99-100%) of the isolates are sensitive to amoxicillin/clavulanic acid, ceftriaxone, and cefuroxime. For antibiotics utilization, macrolides are the predominantly used antibiotics, followed by cephalosporins and penicillins among pediatric patients in the outpatient department during the study period.
All amoxicillin-resistant isolates of H. influenzae are producing beta-Lactamase; and the rates of amoxicillin-resistant isolates are increasing over time. Amoxicillin/clavulanic acid and cephalosporins are highly sensitive to H. influenzae isolated from Chinese pediatric patients. Macrolides are the most used antibiotics in the outpatient department during the study period.
调查5岁以下儿童中流感嗜血杆菌的鼻咽部携带情况及抗菌药物敏感性,并评估2000年至2004年北京儿童医院门诊的抗生素使用模式。
在2000年至2004年期间,于每个研究年度的2月至5月,从5岁以下出现急性上呼吸道感染症状的儿科患者中至少分离出100株流感嗜血杆菌。测定抗菌药物敏感性;抗生素使用情况以限定日剂量(DDD)/100患者日表示。
5岁以下患有急性上呼吸道感染的儿童中,流感嗜血杆菌的总体鼻咽部携带率为26.3%(562/2137)。2000年至2004年期间,氨苄西林耐药菌株的比例从4.0%(4/100)到14.3%(17/119)不等。所有氨苄西林耐药菌株均产β-内酰胺酶。超过80%的菌株对阿莫西林、头孢克洛和氯霉素敏感;而几乎所有(99 - 100%)的菌株对阿莫西林/克拉维酸、头孢曲松和头孢呋辛敏感。对于抗生素使用情况,在研究期间,大环内酯类是门诊儿科患者中使用最主要的抗生素,其次是头孢菌素类和青霉素类。
所有对阿莫西林耐药的流感嗜血杆菌菌株均产β-内酰胺酶;且对阿莫西林耐药菌株的比例随时间增加。阿莫西林/克拉维酸和头孢菌素类对从中国儿科患者分离出的流感嗜血杆菌高度敏感。在研究期间,大环内酯类是门诊使用最多的抗生素。